News Trends, News Analysis, News Archive.



Related Articles

healthNews reuters.com

Critics urge WHO to reverse choice of Mugabe as goodwill envoy

GENEVA/LONDON (Reuters) - The World Health Organization (WHO) should overturn its decision to appoint Zimbabwean President Robert Mugabe as a goodwill ambassador, global health leaders said on Saturday, describing the move as unjustifiable and wrong.

healthNews reuters.com

Critics urge WHO to reverse 'wrong' choice of Mugabe as goodwill envoy

GENEVA/LONDON (Reuters) - The World Health Organisation (WHO) should overturn its decision to appoint of Zimbabwean President Robert Mugabe as a goodwill ambassador, global health leaders said on Saturday, describing the move as unjustifiable and wrong.

healthNews reuters.com

Choice of Mugabe as goodwill WHO envoy shocks, baffles

GENEVA (Reuters) - The appointment of Zimbabwe's President Robert Mugabe as a goodwill ambassador of the World Health Organization (WHO) has been denounced by human rights groups.

healthNews reuters.com

Thailand enters 'War on Sugar' with tax on sweetened beverages

NEW YORK (Reuters) - Thailand has slapped tariffs on sugar likely to hit $9 million worth of U.S. beverage exports, the U.S. Agriculture Department said on Friday, as one of the top producers of the sweetener joins a growing list of regions implementing such taxes.

healthNews reuters.com

Does diabetes make a heart attack feel different?

(Reuters Health) - People with diabetes may not always feel classic symptoms like acute chest pain when they have a heart attack, according to a small study that offers a potential explanation for why these episodes are more deadly for diabetics.

healthNews reuters.com

With time, shoe inserts may help ease plantar heel pain

(Reuters Health) - It could take a little time for orthotic shoe inserts to help relieve plantar heel pain, but the prefabricated versions sold in drugstores may work just as well as more expensive custom alternatives, a recent study suggests.

healthNews reuters.com

Pharmacist's 'deadly' choices sparked U.S. meningitis outbreak: prosecutors

BOSTON (Reuters) - A federal prosecutor told jurors on Friday that a Massachusetts pharmacist gambled with patients' lives by making drugs in unsafe ways that led to a deadly 2012 fungal meningitis outbreak, but a defense lawyer said he was no murderer.

healthNews reuters.com

Follow-up care for acute kidney injury may be lacking

(Reuters Health) - Kidney specialists recommend follow-up care for most patients who have experienced acute kidney injury, but only a minority of patients have been getting that care, according to a Canadian study.

healthNews reuters.com

Frailty, loss of mental function independently affect elderly survival

(Reuters Health) - Frail older people don’t live as long as their stronger peers, and loss of mental function further increases their risk of death, recent research shows.

healthNews reuters.com

FDA teams with medical companies in Puerto Rico to tackle shortages

(Reuters) - The head of the U.S. Food and Drug Administration said the agency was working with several pharmaceutical and medical device companies in Puerto Rico to prevent shortages of medical products in the United States as it joins a massive effort to help rebuild the island that was ravaged by Hurricane Maria.

healthNews reuters.com

Prosecutors seek pharmacist's conviction over U.S. meningitis outbreak

BOSTON (Reuters) - A federal prosecutor on Friday told jurors that a Massachusetts pharmacist, charged with murder for his role in a deadly 2012 U.S. meningitis outbreak, acted with a "depraved heart" while knowingly producing non-sterile drugs.

healthNews reuters.com

Peru Congress passes bill to legalize medical marijuana

LIMA (Reuters) - Peru's conservative Congress passed a bill to legalize medical marijuana late on Thursday with a 68-5 vote in favor of allowing cannabis oil to be produced, imported and commercialized.

healthNews reuters.com

Plague kills 94 in Madagascar, WHO says working to prevent spread

GENEVA (Reuters) - A plague epidemic has killed 94 people on the island of Madagascar and could spread further, the World Health Organization said on Friday.

sportsNews reuters.com

South Korea stresses safety of Pyeongchang Olympics to diplomats, companies

SEOUL (Reuters) - South Korea's foreign ministry stressed the Pyeongchang Olympics will be safe from North Korean provocations in a briefing to diplomats and executives at foreign companies in the country on Friday, as concerns persist over tensions with the North.

healthNews reuters.com

Australia's second largest state edges towards permitting euthanasia

SYDNEY (Reuters) - The parliament of Australia's second largest state passed legislation on Friday to allow terminally ill patients to seek medical help to end their lives, a bill that is expected to act as a catalyst for the rest of the country to adopt similar laws.

healthNews reuters.com

Short on staff: Nursing crisis strains U.S. hospitals

MORGANTOWN, West Virginia (Reuters) - A shortage of nurses at U.S. hospitals hit West Virginia's Charleston Area Medical Center at the worst possible time.

sportsNews reuters.com

South Korea to stress safety of Pyeongchang Olympics to diplomats, companies

SEOUL (Reuters) - South Korea's foreign ministry will stress the Pyeongchang Olympics will be safe from North Korean provocations in a briefing to diplomats and executives at foreign companies in the country on Friday, as concerns persist over tensions with the North.

healthNews reuters.com

White House says rollback of Obamacare must be part of short-term fix

WASHINGTON (Reuters) - A senior White House aide said on Thursday that U.S. President Donald Trump would demand steps toward repealing Obamacare in any healthcare legislation, comments that cast doubt on the prospects for a short-term bill to shore up insurance markets.

healthNews reuters.com

Celgene abandons Crohn's drug trials, shares drop

(Reuters) - Celgene Corp said it would abandon testing a drug to treat Crohn's disease, in a major setback to the U.S. biotechnology company's pipeline amid attempts to lower dependence on its mainstay Revilimid.

healthNews reuters.com

Celgene to stop testing Crohn's drug, shares drop

(Reuters) - Celgene Corp said it would abandon testing a drug to treat Crohn's disease, an inflammatory bowel disease, following a risk-benefit analysis by a data monitoring committee, in a major setback to the drugmaker's pipeline.

healthNews reuters.com

Beauty standards may be broadening

(Reuters Health) - Americans have grown to appreciate beauty across more skin types and ages during the past three decades, if People magazine is any indication, a new study suggests.

healthNews reuters.com

More Republican senators back bipartisan Obamacare deal

WASHINGTON (Reuters) - A bipartisan deal to stabilize Obamacare by restoring billions of dollars of federal subsidies to health insurers picked up Republican support in the Senate on Thursday despite President Donald Trump's opposition but still faced an uphill battle.

healthNews reuters.com

Paleo diet may contribute to iodine deficiency

(Reuters Health) - Older women on a so-called Paleolithic diet – which tries to mimic the diet of cavemen living in the stone age - may be more likely to develop iodine deficiency than their counterparts who don’t eat this way, a small Swedish experiment suggests.

healthNews reuters.com

Bipartisan Obamacare deal gains Republican support in Senate

WASHINGTON (Reuters) - A bipartisan deal to stabilize Obamacare by restoring billions of dollars of subsidies to health insurers picked up Republican support in the Senate on Thursday despite President Donald Trump's opposition.

healthNews reuters.com

Do fewer patients die with female surgeons?

(Reuters Health) - Patients may have better survival odds with female surgeons than with male surgeons, a recent Canadian study suggests.

healthNews reuters.com

Merck cyber attack may cost insurers $275 million: Verisk's PCS

NEW YORK (Reuters) - Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a forecast by Verisk Analytics Inc's Property Claim Services (PCS) unit.

healthNews reuters.com

Senator unveils rare bipartisan healthcare initiative

WASHINGTON (Reuters) - Bipartisan legislation to help stabilize Obamacare was unveiled in the U.S. Senate on Thursday with 22 sponsors in the 100-member chamber, Republican Senator Lamar Alexander said on Thursday.

healthNews reuters.com

New H7N9 bird flu strain in China has pandemic potential: study

CHICAGO (Reuters) - Lab experiments on a new strain of the H7N9 bird flu circulating in China suggest the virus can transmit easily among animals and can cause lethal disease, raising alarms that the virus has the potential for triggering a global human pandemic, researchers reported on Thursday.

healthNews reuters.com

Imprimis Pharma to take on Allergan's Restasis with cheaper product

(Reuters) - Shares of Imprimis Pharmaceuticals sky-rocketed as much as 91.1 percent on Thursday, after it said it would offer a cheaper option to Allergan's dry eye disease medicine, Restasis.

healthNews reuters.com

Insurance a major factor in blacks’ higher breast cancer mortality

(Reuters Health) - African-American women have worse breast cancer survival than white women in the U.S., and a new study suggests that is largely because black women are less likely to have health insurance.

healthNews reuters.com

Ukraine passes long-delayed health reforms praised by West

KIEV (Reuters) - Ukrainian lawmakers voted through a long-delayed overhaul of the health system on Thursday that the state's Western backers say will raise standards and tackle a culture of bribe-taking in surgeries and hospitals.

healthNews reuters.com

FDA approves Gilead cancer gene therapy; price set at $373,000

(Reuters) - U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.

healthNews reuters.com

Uganda confirms one death from Ebola-like Marburg virus

KAMPALA (Reuters) - Uganda has confirmed one death from Marburg virus, a highly infectious hemorrhagic fever similar to Ebola, the health minister said on Thursday.

healthNews reuters.com

Some middle-class Americans worry Trump health subsidies cut will hurt

PHILADELPHIA (Reuters) - Tom Westerman voted for Donald Trump in last year's election but says he might not do so again after the president cut off billions of dollars in Obamacare subsidies to health insurance companies.

healthNews reuters.com

Uganda confirms one case of Ebola-like Marburg virus

NAIROBI (Reuters) - Uganda has confirmed one case of Marburg virus, a highly infectious hemorrhagic fever similar to Ebola, the health minister said on Thursday.

healthNews reuters.com

Novo Nordisk takes aim at Eli Lilly with U.S. backing of new diabetes drug

WASHINGTON/COPENHAGEN (Reuters) - Denmark's Novo Nordisk will take aim at Eli Lilly in the growing diabetes market after an advisory panel to the U.S. Food and Drug Administration (FDA) gave the green light to its semaglutide drug.

cnn.com

War veterans deploy themselves to help Puerto Rico relief

healthNews reuters.com

U.S. FDA approves Gilead cancer gene therapy; price set at $373,000

(Reuters) - U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.

cnn.com

Veterans dismayed by Trump's urge to 'punch back' in feud

President Donald Trump's controversial response to the deaths of four US soldiers has evolved into a politicized war of words with a Democratic congresswoman and -- by extension, the widow of a fallen service member -- sparking concerns that the US civilian-military divide may be at a crisis point.

healthNews reuters.com

Gilead cancer immunotherapy wins U.S. approval with $373,000 price

(Reuters) - A new therapy for a type of lymphoma developed by Kite Pharma, which was acquired by Gilead Sciences Inc, won U.S. approval on Wednesday, marking the second approval for this potentially revolutionary approach to fighting cancer.

healthNews reuters.com

U.S. FDA panel backs approval of Novo Nordisk diabetes drug

WASHINGTON (Reuters) - Novo Nordisk A/S's new diabetes drug semaglutide is effective, reasonably safe and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday.

healthNews reuters.com

White House says Trump opposes Senate's bipartisan Obamacare deal

WASHINGTON (Reuters) - A bipartisan deal from two senators to stabilize Obamacare by restoring subsidies to health insurers suffered major setbacks on Wednesday with the White House saying President Donald Trump now opposes it and senior Republicans speaking out against it.

healthNews reuters.com

White House says Trump opposes bipartisan Senate deal on Obamacare

WASHINGTON (Reuters) - A bipartisan deal from two U.S. senators to stabilize Obamacare by restoring subsidies to health insurers ran into trouble on Wednesday with the White House saying President Donald Trump now opposes it and a senior Senate Republican saying it has stalled.

healthNews reuters.com

Epidurals may not make labor last longer

(Reuters Health) - Giving pregnant women spinal anesthesia known as an epidural to ease their pain during the late stages of labor and delivery may not prolong the process, a new experiment suggests.

healthNews reuters.com

Vitamin D supplements linked to lower risk of asthma attacks

(Reuters Health) - Asthma attacks serious enough to require steroid treatment or hospitalization may be less likely when people take vitamin D supplements, a recent analysis suggests.

healthNews reuters.com

Bipartisan Senate deal on stabilizing Obamacare runs into trouble

WASHINGTON (Reuters) - A bipartisan deal from two U.S. senators to stabilize Obamacare by restoring subsidies to health insurers ran into trouble on Wednesday with President Donald Trump sending mixed signals and the speaker of the House indicating no interest in taking it up.

healthNews reuters.com

Divers with dental work may feel tooth pain under pressure

(Reuters Health) - Divers should talk to their dentists about the effects of underwater pressure and whether dental restorations could become painful, say French researchers.

healthNews reuters.com

Cancer drug prices rising far faster than inflation

(Reuters Health) - The prices of injectable cancer drugs - even older medicines around since the 1990s - are increasing at a rate far higher than inflation, researchers report in the Journal of Clinical Oncology.

healthNews reuters.com

Trump backs away from Senate deal on stabilizing Obamacare

WASHINGTON (Reuters) - President Donald Trump on Wednesday backed away from a bipartisan deal from two U.S. senators to stabilize Obamacare by restoring subsidies to health insurers, one day after signaling his support for the plan.

healthNews reuters.com

Plague ruled out in Seychelles but islands on guard: WHO

GENEVA (Reuters) - Plague has been ruled out in the Seychelles following lab results from 10 patients, including one earlier deemed a "probable" case, the World Health Organization (WHO) said on Wednesday as the disease continued to spread in Madagascar.

healthNews reuters.com

Alnyalm, Vir partner on RNAi-based hep B treatment

(Reuters) - Drug developer Alnylam Pharmaceuticals Inc said on Wednesday it would scrap its hepatitis B (HBV) drug development and instead work with Vir Biotechnology on a new treatment for the disease.

healthNews reuters.com

U.S. Senate backers of Obamacare deal seek support but prospects unclear

WASHINGTON (Reuters) - Proponents of a bipartisan deal struck by two U.S. senators to stabilize Obamacare sought on Wednesday to win Republican support for the measure, which would restore subsidies to health insurers that President Donald Trump has scrapped.

healthNews reuters.com

Health insurer Anthem takes pharmacy business in house, taps CVS to help

(Reuters) - Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding that had deteriorated into lawsuits over terms.

healthNews reuters.com

Shanghai Pharma bids for U.S. Cardinal Health's China business

HONG KONG (Reuters) - Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc's China business as the U.S. company looks to sell ahead of China's planned drug distribution reform.

healthNews reuters.com

Anthem launches new PBM business, signs pact with CVS Health

(Reuters) - Health insurer Anthem Inc said on Wednesday it signed a five-year agreement with drug retailer CVS Health Corp to support its newly launched pharmacy benefit management business.

healthNews reuters.com

Senate backers of deal to stabilize Obamacare seek to build support

WASHINGTON (Reuters) - Proponents of a bipartisan deal struck by two U.S. senators to stabilize Obamacare were seeking on Wednesday to win Republican support for the measure, which would restore subsidies to health insurers that President Donald Trump has scrapped.

healthNews reuters.com

Anthem signs agreement with CVS Health for new PBM business

(Reuters) - Drug retailer CVS Health Corp said on Wednesday it entered into an agreement with Anthem Inc to provide services to the health insurer's newly launched pharmacy benefit management (PBM) business, IngenioRx.

healthNews reuters.com

Novartis says ‍revolade shows long-term disease control for chronic/persistent immune thrombocytopenia​

ZURICH (Reuters) - Novartis said on Wednesday a long term study of ‍its Revolade drug showed good results in treating chronic and persistent immune thrombocytopenia (ITP) - a condition where patients' blood does not clot normally.

Trump, Donald J nytimes.com

Top General’s Grief Becomes Political Talking Point for Trump

President Trump is testing the reluctance of his chief of staff, John F. Kelly, to discuss the death of his son Second Lt. Robert Kelly, who died in combat in 2010.

healthNews reuters.com

Allergan ruling casts doubt on tribal patent strategy

(Reuters) - A U.S. judge’s ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts said.

healthNews reuters.com

Frailty tied to higher risk of complications with common surgeries

(Reuters Health) - Frail patients are more likely to have serious complications after elective outpatient surgery than people who are healthier and stronger, a recent study suggests.

healthNews reuters.com

Should donor sex influence blood transfusion practices?

(Reuters Health) - Sick or injured men who receive blood transfusions may be more likely to die if their donor was a woman who has been pregnant in the past, a new study suggests.

healthNews reuters.com

Florida needs more pet-friendly hurricane shelters for the elderly

(Reuters Health) - When pet owners need to flee from disasters like hurricanes and fires, they often think first of their animals, but a new study suggests a scarcity of pet-friendly emergency shelters could make older evacuees all the more vulnerable.

healthNews reuters.com

UnitedHealth sees growth in 2018, opportunities in Trump plans

(Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, said earnings will grow 13 to 16 percent in 2018 as medical costs remain low, and that it expects to benefit from new insurance products backed by U.S. President Donald Trump.

healthNews reuters.com

Johnson & Johnson wins reversal of $72 million verdict over talc cancer risks

(Reuters) - Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.

healthNews reuters.com

J&J wins reversal of $72 million verdict over talc cancer risks

(Reuters) - Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.

healthNews reuters.com

Fatty liver disease fastest-growing reason for transplants in young U.S. adults

(Reuters Health) - Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplants in young Americans, according to a recent study.

healthNews reuters.com

UnitedHealth sees growth in 2018, a year of changes by Trump

(Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer,

healthNews reuters.com

U.S. indicts two Chinese in major fentanyl trafficking case

WASHINGTON (Reuters) - The U.S. Department of Justice said on Tuesday it has indicted two major Chinese drug traffickers on charges of making and selling highly addictive fentanyl to Americans over the internet.

healthNews reuters.com

Drugmakers Amneal, Impax to combine in generics push

(Reuters) - Amneal Pharmaceuticals LLC is buying peer Impax Laboratories Inc in an all-stock deal as it looks to add heft to its generics business and gain an edge in a tough drug pricing environment.

healthNews reuters.com

China confirms bird flu outbreak at poultry farms in central province

BEIJING (Reuters) - China on Tuesday confirmed an outbreak of bird flu at broiler chicken farms in a central province, the Ministry of Agriculture said in a statement.

healthNews reuters.com

Japan's "Blade Library" offers joy of blade running to amputees

TOKYO (Reuters) - Haruta Saito, a young Japanese amputee who dreams of becoming a Paralympian, remembers strapping on a prosthetic "running blade" for the first time.

healthNews reuters.com

Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors

LONDON (Reuters) - An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines.

healthNews reuters.com

Trump says he could jettison drug czar pick

WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday he would review a report that his nominee for drug czar championed a law that weakened the government's ability to fight the nation's opioid epidemic, and said he could consider jettisoning the pick.

healthNews reuters.com

Regeneron-Sanofi drug succeeds mid-stage study

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.

healthNews reuters.com

Intensive resistance training safe, effective for women with osteoporosis

(Reuters Health) - High-intensity resistance and impact training (HiRIT) may improve bone and muscle strength in select postmenopausal women with osteoporosis, according to a small study in Australia.

healthNews reuters.com

More men than women infected with oral human papillomavirus

(Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests.

healthNews reuters.com

Trump says he will 'look into' drug czar pick following report

WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday that he would "look into" a report that his nomination for drug czar championed a law weakening the Drug Enforcement Administration's capacity to slow the flow of drugs that have fueled the country's opioid epidemic.

healthNews reuters.com

Trump says administration to make opioid announcement next week

WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday that his administration would likely make an announcement next week on the opioid crisis, which a White House commission suggested should be declared a national emergency.

healthNews reuters.com

Some mothers may not seek early help for kids with developmental delays

(Reuters Health) - When mothers trust their friends and neighbors more than doctors or struggle to access or afford care, they may be less likely to seek out medical help for young kids with developmental delays, a small U.S. study suggests.

healthNews reuters.com

Mothers’ exposure to air pollution tied to cellular changes in kids

(Reuters Health) - Women who breathe polluted air during pregnancy have babies with greater signs of “aging” in their cells when they’re born compared to babies whose mothers breathed cleaner air, a new study finds.

healthNews reuters.com

Exelixis drug improves overall survival in liver cancer patients

(Reuters) - Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent.

healthNews reuters.com

Novo Nordisk diabetes drug works; no heart risk-FDA review

(Reuters) - Novo Nordisk A/S's closely watched diabetes drug semaglutide is effective, caused no heart risk, and carried only limited risk of sight problems, a preliminary review by the U.S. Food and Drug Administration concluded on Monday, sending the company's shares up 4 percent.

healthNews reuters.com

Israel targets fashion industry over underweight models

TEL AVIV (Reuters) - Israeli lawmakers want to tighten a ban on the employment of underweight models and on the undeclared digital slimming-down of fashion images, amid concern that the measures are being routinely flouted even as they are adopted abroad.

healthNews reuters.com

Aimmune teams with Regeneron, Sanofi on peanut allergy drug

(Reuters) - Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.

healthNews reuters.com

Regeneron-Sanofi food allergy drug succeeds mid-stage study

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat infection in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.

California Today nytimes.com

California Today: California Today: Talking to a Democratic Challenger for Feinstein

Monday: A conversation with Kevin de León, the end in sight for wildfires, and the debut of Disney.

healthNews reuters.com

Novo Nordisk diabetes drug effective, preliminary FDA review finds

(Reuters) - Novo Nordisk A/S's closely watched diabetes drug semaglutide is effective, a preliminary review by the U.S. Food and Drug Administration concluded, sending the company's shares up 3.4 percent in premarket trading on Monday.

healthNews reuters.com

Regeneron-Sanofi throat infection drug succeeds key study

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat patients with a rare throat infection met the main goal of a mid-stage study.

healthNews reuters.com

Exelixis liver cancer drug meets late-stage goal, shares jump

(Reuters) - Exelixis Inc said on Monday its drug to treat patients with a type of liver cancer met the main goal in a late stage study, sending its shares up 19 percent in premarket trading.

healthNews reuters.com

Madagascar plague appears to have spread to Seychelles: WHO

GENEVA (Reuters) - A probable case of plague in the Seychelles, imported from Madagascar, is believed to have sparked the Indian Ocean country's first outbreak of the disease, the World Health Organization (WHO) said.

businessNews reuters.com

Toyota to test self-driving, talking cars by about 2020

TOKYO (Reuters) - Toyota Motor Corp on Monday said it would begin testing self-driving electric cars around 2020, which will use artificial intelligence (AI) to engage with drivers, as the company competes with tech firms to develop new vehicles.

companyNews reuters.com

Three biggest U.S. clearing houses pass liquidity stress tests -CFTC

* Concerns growing that clearing houses are "too big to fail"

healthNews reuters.com

Trump Obamacare move seen harming Americans, bipartisan prospects

WASHINGTON (Reuters) - U.S. President Donald Trump will hurt low-income Americans by doing away with Obamacare subsidies and make it harder for him to engage in bipartisan talks with Democrats as Congress edges toward a possible government shutdown, lawmakers said on Sunday.

healthNews reuters.com

U.S. states sue to block Trump Obamacare subsidies cut

WASHINGTON/SAN FRANCISCO (Reuters) - Eighteen U.S. states sued President Donald Trump's administration on Friday to stop him from scrapping a key component of Obamacare, subsidies to insurers that help millions of low-income people pay medical expenses, even as Trump invited Democratic leaders to negotiate a deal.

healthNews reuters.com

WHO says attack on Syria vaccine store leaves children at risk

LONDON (Reuters) - The World Health Organization said on Friday it had received reports of an attack on medical facilities in eastern Syria that had destroyed a store containing more than 130,000 vaccine doses against measles and polio.

healthNews reuters.com

After medical errors, patients want doctors to hear them out

(Reuters Health) - When medical errors lead to serious injuries, patients and families may feel better when doctors take the time to listen to their feelings about the mistake and explain what can be done to prevent it from happening again, a small study suggests.

healthNews reuters.com

J&J psoriasis drug gets expanded U.S. approval for teens

(Reuters) - Johnson & Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients aged 12 and over with moderate to severe cases of the unsightly skin condition.

healthNews reuters.com

Aspirin habits unchanged by recommendations from U.S. doctors

(Reuters Health) - U.S. guidelines urging more adults who never had a heart attack or stroke to take a daily aspirin may not have convinced people to take these pills, a recent study suggests.

healthNews reuters.com

Little evidence new cancer drugs improve survival

(Reuters Health) - There’s not much evidence to show that most new cancer drugs approved in Europe in recent years can help patients live longer or improve their quality of life, a recent study suggests.

healthNews reuters.com

U.S. states plan suit to block Trump Obamacare subsidies cut

WASHINGTON (Reuters) - A coalition of U.S. states lined up on Friday to sue to block President Donald Trump's move to scrap a key component of Obamacare, subsidies to health insurers that help low-income Americans pay out-of-pocket medical expenses.

healthNews reuters.com

GlaxoSmithKline's shingles vaccine gets approval in Canada

(Reuters) - Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday.

companyNews reuters.com

UPDATE 2-Ivascyn's Pimco Income fund surpasses $100 bln despite fee hike –sources

NEW YORK, Oct 13 (Reuters) - The Pimco Income Fund (PIMIX), widely seen by investors and analysts as Pacific Investment Management’s new flagship fund, surpassed $100 billion in assets under management this week, even as fees were hiked on Oct. 2, two sources familiar with the matter said Friday.

healthNews reuters.com

U.S. FDA panel backs Aerie's glaucoma drug Rhopressa

(Reuters) - Aerie Pharmaceuticals Inc's experimental glaucoma treatment should be approved, an advisory committee to the U.S. Food and Drug Administration said on Friday, after it found the benefits outweigh the risks.

healthNews reuters.com

Trump ends key insurance subsidies, vows to dismantle Obamacare

WASHINGTON (Reuters) - U.S. President Donald Trump on Friday pledged to dismantle Obamacare "step by step" after he scrapped subsidies to health insurers that help low-income Americans pay out-of-pocket medical expenses, a move that raised concerns about chaos in insurance markets and could face legal challenges.

companyNews reuters.com

Ivascyn's Pimco Income fund surpasses $100 bln despite fee raise –sources

NEW YORK, Oct 13 (Reuters) - The Pimco Income Fund (PIMIX), widely seen by investors and analysts as Pacific Investment Management’s new flagship fund, surpassed $100 billion in assets under management this week in spite of increasing management fees set on October 2, two sources familiar with the matter said Friday.

healthNews reuters.com

UK anti-trust regulator investigates South Africa's Aspen Pharmacare

JOHANNESBURG (Reuters) - Britain's competition regulator has launched an investigation into Africa's biggest generic drug maker Aspen Pharmacare over alleged anticompetitive conduct in the supply of blood pressure and arthritis drugs, Aspen said on Friday.

healthNews reuters.com

Milan hopes to gain from Barcelona's pain in race for EU drugs agency

MILAN (Reuters) - Milan is hoping that Spain's Catalonia crisis will give the Italian city a boost in getting to host the European Medicines Agency (EMA), the European Union agency quitting London because of Brexit.

healthNews reuters.com

Trump scraps key Obamacare subsidies, urges Democrats to fix 'broken mess'

WASHINGTON (Reuters) - U.S. President Donald Trump on Friday urged Democrats to make a healthcare deal after cutting off Obamacare subsidies to health insurance companies for low-income patients in a forceful move that sparked threats of legal action and concern of chaos in insurance markets.

healthNews reuters.com

Tourniquets, once out of favor, helped save lives in Vegas shootings

LAS VEGAS (Reuters) - When the sniper’s bullet shattered Paola Bautista’s arm, her sister and a stranger in the crowd at the Route 91 Harvest Festival got her to cover. Then they focused on the bleeding.

healthNews reuters.com

Nursing degrees increasing, but not on track to meet goal for acute care

(Reuters Health) - The proportion of registered nurses with nursing bachelor’s degrees has climbed in recent years to 57 percent in U.S. acute care settings, but it’s not rising fast enough to reach a goal of 80 percent by the year 2020, researchers say.

Fallon, Jimmy nytimes.com

Best of Late Night: Seth Meyers Can’t Believe Trump Is Talking About Pulling Troops From Puerto Rico

On “Late Night,” Mr. Meyers reminded the president that it’s been just three weeks since Hurricane Maria.

healthNews reuters.com

Trump nails Obamacare with decision to cut off billions in subsidies

WASHINGTON (Reuters) - U.S. President Donald Trump moved to undermine Obamacare dramatically late on Thursday by cutting off subsidies to health insurance companies for low-income patients, sparking threats of legal action and concern of chaos in insurance markets.

healthNews reuters.com

White House says it can't lawfully pay Obamacare subsidies

WASHINGTON (Reuters) - President Donald Trump will stop payments worth billions of dollars to health insurers to subsidize low-income Americans, the White House said on Thursday, a move health insurers have warned will cause chaos in insurance markets and a spike in premiums.

healthNews reuters.com

Trump healthcare order could run afoul of retirement plan law

(Reuters) - President Donald Trump's plan to make it easier for small businesses to band together and buy stripped-down health insurance plans could violate a federal law governing employee benefit plans and will almost certainly be challenged in court, legal experts said.

healthNews reuters.com

FDA panel backs gene therapy for rare form of blindness

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.

healthNews reuters.com

Frustrated by Congress, Trump signs order to weaken Obamacare

WASHINGTON (Reuters) - President Donald Trump on Thursday signed an order to make it easier for Americans to buy bare-bones health insurance plans, using his presidential powers to undermine Obamacare after fellow Republicans in Congress failed to repeal the 2010 law.

healthNews reuters.com

After concussion, teen girls may take longer to heal than boys

(Reuters Health) - Female adolescent athletes may take more than twice as long to recover from concussions as their male counterparts, a small study suggests.

healthNews reuters.com

Trump's not-so-quick fix to undo Obamacare

NEW YORK (Reuters) - President Donald Trump on Thursday prescribed a quick fix to undo Obamacare through executive order after Republicans in the U.S. Congress failed to repeal and replace the healthcare law as promised, but industry experts said there are many steps involved that will slow it down.

healthNews reuters.com

Sanofi boosts vaccines business with 170 million euro investment

VAL-DE-REUIL, France (Reuters) - Sanofi on Thursday expressed confidence in the growth of its influenza vaccines after committing to invest 170 million euros to expand its manufacturing facility at Val-de-Reuil in north-western France.

healthNews reuters.com

Even slightly-early birth linked to lower cardiorespiratory fitness

(Reuters Health) - Babies born a little early, but still within the range considered “full term,” may have worse cardiorespiratory fitness than peers born after a full 39 weeks of gestation, suggests a recent study.

healthNews reuters.com

Cardiac arrest survival odds may rise with public CPR training

(Reuters Health) - Training more community members, patients and families to recognize and respond to a cardiac arrest before medical help arrives may help more victims survive, a U.S. study suggests.

healthNews reuters.com

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

(Reuters) - The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer.

healthNews reuters.com

Trump signs order to weaken Obamacare, boost bare-bones insurance

WASHINGTON (Reuters) - President Donald Trump signed an executive order on Thursday to weaken the Obamacare law and make it easier for Americans to buy bare-bones health insurance plans, but the action faces possible legal challenges.

healthNews reuters.com

AcelRx Pharma shares sink as FDA rejects opioid painkiller

(Reuters) - Shares of AcelRx Pharmaceuticals Inc plunged more than 60 percent on Thursday after the U.S. Food and Drug Administration declined to approve its opioid painkiller Dsuvia.

healthNews reuters.com

Trump to sign order circumventing Obamacare rules

WASHINGTON (Reuters) - President Donald Trump will sign an executive order on Thursday to make it easier for Americans to buy bare-bones health insurance plans and circumvent Obamacare rules, the White House said, but the action faces possible legal challenges.

healthNews reuters.com

NIH partners 11 drugmakers to accelerate cancer therapy research

(Reuters) - The National Institutes of Health said on Thursday it had partnered 11 biopharma companies to help advance a new class of drugs that uses the body's immune system to fight cancer.

healthNews reuters.com

Virtual interviewer prods veterans to reveal post-traumatic stress

(Reuters Health) - Talking – to a computer-generated interviewer named Ellie – appears to free soldiers and veterans who served in war zones to disclose symptoms of post-traumatic stress, a new study finds.

healthNews reuters.com

Swedish prosecutor says will not charge Italian stem cell surgeon

STOCKHOLM (Reuters) - Swedish prosecutors said on Thursday they were ending without charges an investigation into surgeon Paolo Macchiarini after finding no legal evidence he caused the death of three patients.

healthNews reuters.com

'Double whammy' for Roche as manufacturing patent losses loom

ZURICH (Reuters) - Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed.

healthNews reuters.com

AcelRx Pharma shares sink as FDA rejects its opioid painkiller

(Reuters) - AcelRx Pharmaceuticals Inc's shares plunged more than 60 percent before the bell on Thursday after the U.S. Food and Drug Administration rejected the drugmaker's opioid painkiller in its present form.

healthNews reuters.com

Trump expected to sign order side-stepping Obamacare rules

WASHINGTON (Reuters) - President Donald Trump was expected to sign an executive order on Thursday that would make it easier for Americans to buy bare-bones health insurance plans and circumvent rules put in place by Obamacare, though such an order could face legal challenges.

healthNews reuters.com

SGS and Bavarian Nordic developing challenge strain to combat respiratory virus​

ZURICH (Reuters) - SGS and Bavarian Nordic are teaming up to develop a virus challenge strain to combat a common respiratory illness.

healthNews reuters.com

Sanofi invests 170 million euros in French vaccines facility

PARIS (Reuters) - Sanofi will invest 170 million euros ($202 million) to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a drive aimed at boosting the production of one of its influenza vaccines.

healthNews reuters.com

Trump healthcare order could face strong legal objections

(Reuters) - U.S. President Donald Trump's expected plan to let Americans buy insurance across state lines could violate federal law governing employee benefit plans and will almost certainly be challenged in court, several legal experts said.

healthNews reuters.com

Merck says will not seek approval of cholesterol treatment

(Reuters) - Merck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile of the treatment does not support regulatory filings.

healthNews reuters.com

Prostate cancer patients unclear on differences among treatments

(Reuters Health) - Many patients with localized prostate cancer don’t understand the differences between their treatment options, a new study suggests.

healthNews reuters.com

Marital ups and downs tied to shifts in heart health

(Reuters Health) - Married men who see their relationship with their spouse improve over the years may also experience positive changes in their health that can lower the risk of heart disease, a recent U.K. study suggests.

healthNews reuters.com

Ardelyx's constipation drug succeeds in late-stage trial

(Reuters) - Ardelyx Inc said on Wednesday a second late-stage trial of its experimental drug for irritable bowel syndrome with constipation (IBS-C) met the main goal of reducing abdominal pain and increasing bowel movement.

healthNews reuters.com

For some kids, bullying may not leave lasting mental scars

(Reuters Health) - Children who are bullied during their pre-teen years may experience mental health issues like anxiety and depression, but a study of twins suggests that some victims may not experience lasting psychological problems.

healthNews reuters.com

U.S. government undercounted civilians killed by police

(Reuters Health) - U.S. police killed 1,166 people - more than three a day - in 2015, but an official government count missed a majority of the deaths, a new study shows.

healthNews reuters.com

Italy culls birds after five H5N8 avian flu outbreaks in October

ROME (Reuters) - Italy has had five outbreaks of highly pathogenic H5N8 avian flu in farms the central and northern parts of the country since the start of the month and about 880,000 chickens, ducks and turkeys will be culled, officials said on Wednesday.

healthNews reuters.com

Aerie's glaucoma drug effectively lowers eye pressure: FDA review

(Reuters) - Aerie Pharmaceuticals Inc's experimental glaucoma treatment Rhopressa is effective in lowering eye pressure, a preliminary review by the U.S. Food and Drug Administration concluded.

companyNews reuters.com

UPDATE 2-UK energy price cap will not start this winter – Ofgem

* New Ofgem measure to project 1 mln households next Feb (Updates throughout and with regulator comment on timings)

healthNews reuters.com

Philips sees profit hit from U.S. defibrillator blow

AMSTERDAM (Reuters) - Health technology company Philips is suspending the manufacture of some defibrillators in the United States and will make others under heightened scrutiny following criticisms from U.S. regulators, in a move it said would dent profits.

healthNews reuters.com

Philips to suspend making some defibrillators in U.S.; profits hit

AMSTERDAM (Reuters) - Philips, Dutch healthcare technology company, said on Wednesday it would suspend manufacturing some defibrillators in the United States and continue making others under heightened scrutiny by the U.S. Food and Drug Administration.

healthNews reuters.com

Philips must suspend making some defibrillators in U.S.; profits hit

AMSTERDAM (Reuters) - Dutch healthcare technology company Philips said on Wednesday it had agreed to suspend manufacturing some defibrillator devices in the United States and would continue making others under heightened scrutiny by the Food and Drug Administration.

healthNews reuters.com

Trump names Eric Hargan as acting Health Secretary

(Reuters) - President Donald Trump has appointed Eric Hargan as acting Secretary of Health and Human Services (HHS), the White House said on Tuesday.

healthNews reuters.com

Child and teen obesity soars tenfold worldwide in 40 years: WHO report

GENEVA (Reuters) - The number of obese children and adolescents worldwide has jumped tenfold in the past 40 years and the rise is accelerating in low- and middle-income countries, especially in Asia, a major study said on Wednesday.

healthNews reuters.com

Can insulin pumps work better than injections for kids with diabetes?

(Reuters Health) - Children and teens with type 1 diabetes who use insulin pumps may have better-controlled blood sugar and fewer complications than youth who inject insulin, a new study suggests.

healthNews reuters.com

Tests showing low egg reserves not linked to infertility

(Reuters Health) - Lab tests showing that women have low reserves of eggs in their ovaries may not necessarily mean they will struggle to get pregnant, a U.S. study suggests.

healthNews reuters.com

Pharma's Puerto Rico problems could mean drug shortages: FDA chief

NEW YORK (Reuters) - The head of the U.S. Food and Drug Administration said on Tuesday the country may start to see a small number of drug shortages within two or three weeks due to delays in restoring manufacturing operations in Puerto Rico, where 10 percent of drugs prescribed in the United States are made.

healthNews reuters.com

Many patients remain confused about medical hierarchy

(Reuters Health) - Patients continue to be confused about the roles and responsibilities different doctors play in their health care, new research confirms.

Freedom of Speech and Expression nytimes.com

Talking About the N.F.L. Protests With Kids

Americans may express their opinions without fear of punishment from the government – but free speech isn’t always extended to school-age kids.

healthNews reuters.com

Trump says he's likely to sign healthcare order this week

WASHINGTON (Reuters) - President Donald Trump said on Tuesday he likely will sign an order this week that is expected to allow Americans to buy stripped-down health insurance policies, a step some experts say would further undermine the Obamacare law that Trump opposes.

healthNews reuters.com

Doctors may fear losing their license for seeking mental health care

(Reuters Health) - Nearly 40 percent of U.S. physicians are reluctant to seek mental health care out of fear that it might imperil their medical license, a recent study suggests.

healthNews reuters.com

Lilly's breast cancer drug fails to help lung patients

(Reuters) - Eli Lilly and Co said its recently approved breast cancer drug failed to meet a late-stage trial's main goal of improving overall survival in patients with non-small cell lung cancer.

healthNews reuters.com

Trump says likely to sign new healthcare order this week

WASHINGTON (Reuters) - President Donald Trump said on Tuesday he would sign a measure, likely this week, to allow people in the United States to buy healthcare across state lines.

healthNews reuters.com

UK lawmakers join protest tea party to support medicinal marijuana

LONDON (Reuters) - Several British lawmakers lent their support to a cannabis tea party on the lawns outside parliament on Tuesday, protesting against legislation that criminalizes use of the drug for medical purposes.

healthNews reuters.com

Spark gene therapy improves vision, at least in short term: FDA

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness improves vision, though it is unclear whether the benefit lasts over time, according to a preliminary review by the U.S. Food and Drug Administration.

healthNews reuters.com

Lilly's lung cancer drug fails main goal of key study

(Reuters) - Eli Lilly and Co said its drug to treat non-small cell lung cancer failed to meet the main goal of improving overall survival in patients in a late-stage trial, sending its shares down about 3 percent.

healthNews reuters.com

U.S. FDA finds Spark's blindness treatment initially effective

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness is effective, though it is unclear whether the benefit lasts over time, according to a preliminary review by the U.S. Food and Drug Administration.

healthNews reuters.com

Spark's blindness gene therapy reviewed by U.S. FDA

(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare inherited form of blindness is effective, though it is unclear whether the benefit lasts over time, according to a preliminary review by the U.S. Food and Drug Administration.

healthNews reuters.com

Lilly's lung cancer drug fails late-stage study

(Reuters) - Eli Lilly and Co said on Tuesday its drug to treat non-small cell lung cancer failed to meet the main goal of improving overall survival in patients in a late-stage study.

topNews reuters.com

Investigators talking to brother of gunman in Las Vegas shooting

(Reuters) - Investigators are talking to the brother of a gunman who killed 58 people in Las Vegas last week before he shot himself to death as they seek to determine what motivated the mass shooting, officials said Monday.

healthNews reuters.com

Heartburn symptoms tied to psychological factors in some patients

(Reuters Health) - Heartburn sufferers who don’t feel better with standard treatment, but who have no detectable reflux, tend to have greater distress and worse quality of life, according to a new study.

companyNews reuters.com

UPDATE 2-Apple praises French iPhone work before talking tax with Macron

PARIS, Oct 9 (Reuters) - Apple boss Tim Cook went out of his way on Monday to single out a small French firm involved with innovative features in the latest iPhones ahead of meeting with President Emmanuel Macron, who has called for a tougher line on technology company taxes.

healthNews reuters.com

California governor signs drug pricing transparency law

(Reuters) - California Governor Jerry Brown on Monday signed state legislation requiring drug companies to report certain price hikes for prescription medicines in a move that could set a model for other states could follow.

businessNews reuters.com

Apple praises French iPhone work before talking tax with Macron

PARIS (Reuters) - Apple boss Tim Cook went out of his way on Monday to single out a small French firm behind innovative features in the latest iPhones ahead of meeting with President Emmanuel Macron, who has called for a tougher line on technology company taxes.

companyNews reuters.com

UPDATE 1-Apple praises French iPhone work before talking tax with Macron

* France has proposed a tax on revenues (Adds presidential adviser on Macron-Cook meeting)

healthNews reuters.com

Concussion leads to post-career mental issues: FIFPro study

LONDON (Reuters) - Athletes who suffer concussions during their careers are more prone to anxiety, depression and sleep disturbance after retirement, according to new research by soccer's world players' union FIFPro.

healthNews reuters.com

Terror attacks in U.S. more likely than elsewhere to involve guns

(Reuters Health) - Terrorist attacks are much more likely to involve firearms in the U.S. than in many other high-income industrialized countries, a new study suggests.

healthNews reuters.com

Injuries on stairs occur in all age groups and abilities

(Reuters Health) - More than 1 million Americans injure themselves on stairs each year, according to a study in the American Journal of Emergency Medicine.

healthNews reuters.com

Aggressive breast cancer treatment tied to more missed work

(Reuters Health) - Many women with early-stage breast cancer have full-time jobs when they’re diagnosed, and they are more likely to miss at least a month of work when they receive aggressive treatment that includes surgery, a U.S. study suggests.

businessNews reuters.com

Apple praises French iPhone work before meeting tough-talking Macron

PARIS (Reuters) - Apple boss Tim Cook went out of his way on Monday to single out a small French firm behind innovative features in the latest iPhones ahead of meeting with President Emmanuel Macron, who has called for a tougher line on technology company taxes.

healthNews reuters.com

Cholera claims unborn children as epidemic spreads Yemen misery

HODEIDAH, Yemen (Reuters) - One of the latest victims of the cholera epidemic that has killed more than 2,000 people in Yemen had yet to even take her first breath.

healthNews reuters.com

UK's Prince Harry says troops need mental as well as physical fitness combat training

LONDON (Reuters) - Britain's Prince Harry said on Monday the mental health of serving soldiers was as important as ensuring they were ready to take part in conflicts.

healthNews reuters.com

China to accept overseas trial data in bid to speed up drug approvals

SHANGHAI (Reuters) - China said it plans to accept data from overseas clinical trials to speed up approvals of drugs, a potential boon for international drugmakers as well as patients who often face lengthy delays for new medicines to reach the market.

healthNews reuters.com

China to speed up drug approvals, will accept overseas trial data

SHANGHAI (Reuters) - China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market.

Restaurants nytimes.com

Grace Notes: An Architect Designed a Calmer Restaurant. It Was Very Stressful.

Brad Cloepfil redesigned the multistarred Eleven Madison Park — not just the room but everything down to the tables, the plates, and the cups and saucers.

healthNews reuters.com

Flexion's knee pain drug gets FDA nod, shares hit life high

(Reuters) - Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday.

healthNews reuters.com

Fewer newborns get whooping cough when moms get vaccinated

(Reuters Health) - Vaccinating mothers against whooping cough during pregnancy may prevent 9 out of 10 severe cases of this potentially fatal respiratory infection in their babies, a U.S. study suggests.

healthNews reuters.com

Some police and retailers may store guns to help prevent suicide

(Reuters Health) - Most law enforcement agencies and many gun retailers may be willing to temporarily store firearms to help prevent suicide, a recent U.S. study suggests.

healthNews reuters.com

FDA approves Flexion's knee pain drug, shares surge

(Reuters) - Flexion Therapeutics Inc said on Friday the U.S. Food and Drug Administration approved its injectable drug, Zilretta, to treat moderate-to-severe osteoarthritis-related knee pain, sending its shares soaring 18 percent.

healthNews reuters.com

Trump undermines U.S. birth control coverage requirement

WASHINGTON/NEW YORK (Reuters) - President Donald Trump's administration on Friday undermined requirements under the Obamacare law that employers provide insurance to cover women's birth control, keeping a campaign pledge that pleased his conservative Christian supporters.

healthNews reuters.com

Weight loss surgery linked to lower risk of cancer

(Reuters Health) - Severely obese people who undergo surgery to shed excess pounds may have lower odds of developing cancer than they would without the operations, a recent U.S. study suggests.

healthNews reuters.com

In Puerto Rico, lives depend on volunteer doctors and diesel generators

OROCOVIS, Puerto Rico (Reuters) - At a community center in Orocovis, an isolated agricultural town of 23,000 in the mountains of central Puerto Rico, six oxygen-dependent patients drew breath only with the help of the diesel generator powering their equipment.

healthNews reuters.com

U.S. exempts more employers from covering birth control

WASHINGTON/NEW YORK (Reuters) - The U.S. government on Friday made several targeted moves to circumvent the mandate under Obamacare that health insurance provide birth control.

healthNews reuters.com

Anxiety, depression greatest in younger kids with facial birth defects

(Reuters Health) - Elementary school children with cleft lip, cleft palate and other facial anomalies may struggle more than older kids with anger, anxiety, depression and stress, according to a recent study.

healthNews reuters.com

Bayer sticks by Xarelto sales estimate despite study setback

FRANKFURT/BERLIN (Reuters) - Bayer stood by its peak sales estimate for clot prevention drug Xarelto after the pill disappointed in a late-stage trial to test prevention of repeat strokes.

healthNews reuters.com

Cash injection: sovereign funds target healthcare

LONDON (Reuters) - Imagine contact lenses that monitor glucose levels for diabetics, tiny implants to tackle chronic diseases, or algorithms that crunch data to predict illness rates.

healthNews reuters.com

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement.

healthNews reuters.com

At least six funds interested in Sanofi European generic drugs unit -Le Figaro

PARIS (Reuters) - French pharmaceutical group Sanofi is set to start the process to sell its generic drug business in Europe, and at least six funds have expressed interest to investment banks mandated by group, France's Le Figaro newspaper reported.

healthNews reuters.com

Many women with disabilities don’t get cancer screening

(Reuters Health) - Women with physical and mental disabilities may be less likely to receive recommended screenings for breast or bowel cancers than other patients, a UK study suggests.

healthNews reuters.com

Car crash death rates highest in remotest rural areas

(Reuters Health) - Car crash death rates get increasingly high as population density drops, fueled in part by lower seat belt use in the remotest rural areas, a U.S. study suggests.

healthNews reuters.com

Elderly with dementia at risk for inappropriate medications

(Reuters Health) - More than half of elderly patients with dementia are prescribed at least one potentially inappropriate medication, a recent study from eight European countries suggests.

healthNews reuters.com

Teva's Copaxone faces generic competition in Europe after U.S. hit

LONDON (Reuters) - Teva's blockbuster multiple sclerosis treatment Copaxone will face additional generic competition in Europe, just two days after Mylan NV won U.S. approval to sell cheaper versions of the medicine in the world's largest market.

healthNews reuters.com

U.S. court reverses ban on sale of Regeneron, Sanofi cholesterol drug

(Reuters) - A U.S. appeals court on Thursday threw out a ban on the sale of Regeneron Pharmaceuticals Inc and Sanofi SA's cholesterol-lowering drug Praluent, and ordered a new trial after finding a jury was given improper instructions.

healthNews reuters.com

New Jersey sues Insys as opioid maker settles with Massachusetts

BOSTON (Reuters) - New Jersey on Thursday accused Insys Therapeutics Inc of engaging a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations.

healthNews reuters.com

Industry messages on responsible drinking can be muddy

(Reuters Health) - The language used in industry-sponsored messages about drinking alcohol, such as “drink responsibly” and “drink properly,” doesn’t do a good job of explaining to the public what safe alcohol consumption means, suggests a recent study.